Mr. Dave Dingwall (Cape Breton-East Richmond):
Mr. Speaker, the Government is attempting to cover up the true facts about Bill C-22 and its impact on the cost of drugs in Canada.
On three separate occasions in the House the Minister of Consumer and Corporate Affairs (Mr. Andre) and the Minister of National Health and Welfare (Mr. Epp) alluded to the fact that they would produce for members of the legislative committee studying Bill C-22 the cost implication studies which were carried out by Consumer and Corporate Affairs.
In a motion recently put before the legislative committee, Conservative Members voted down the request to have the Minister of National Health and Welfare or the Minister or Consumer and Corporate Affairs provide the information to the committee so that all members would have an opportunity to view first-hand the cost implications of Bill C-22.
It is a further example of the Conservative majority on that committee, the Conservative majority in the House, trying to hoodwink Canadians into believing that the amendments in Bill C-22 will have a positive effect upon senior citizens and disabled people in Canada.
I call upon the Government to provide the necessary information so that Canadians can judge the ruthless type of action the Government is taking.
Subtopic: PHARMACEUTICAL INDUSTRY
Sub-subtopic: PROCEEDINGS IN COMMITTEE STUDYING PATENT LAW AMENDING BILL